BlossomHill Therapeutics, Inc. Common Stock (BLSM) is a publicly traded the market company. As of August 10, 2026, BLSM trades at $16.05 with a market cap of $465.30M and a P/E ratio of 0.00. BLSM moved +0.13% today. Year to date, BLSM is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $15.25 to $17.25. Rallies surfaces BLSM's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
The average price target is $0.00.
| Metric | Value |
|---|---|
| Price | $16.05 |
| Market Cap | $465.30M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $17.25 |
| 52-Week Low | $15.25 |
| Volume | 414.31K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
BLSM analyst coverage data. Average price target: $0.00.